Skip to content
Kamply
An ad Substrate ARC: Autonomous Revenue Cycle is running
The creative as the library shows it, copied to our own storage.
Substrate ARC: Autonomous Revenue Cycle

A $100M net patient revenue practice loses up to $18M to denial leakage, slow AR, and…

Platform
LinkedIn
Format
Image
Countries
US
Category
B2B software
Read on
29 August 2026

The copy, as stored

A $100M net patient revenue practice loses up to $18M to denial leakage, slow AR, and cost-to-collect drag. Substrate AR… The EBITDA waterfall on a $100M practice.

See it in the LinkedIn libraryRead the Substrate ARC: Autonomous Revenue Cycle competitor brief

Where Substrate ARC: Autonomous Revenue Cycle stands, from its brief

They position Substrate as an autonomous healthcare revenue-cycle system that recovers denied revenue and improves practice economics. Their ads rely on repeated proof points around denial leakage, fast deployment, hands-free work, and EBITDA impact. You can compete by making your mechanism, measurement rules, implementation effort, and human controls more explicit.

More from Substrate ARC: Autonomous Revenue Cycle

Every Substrate ARC: Autonomous Revenue Cycle ad

Seen the angle you want to answer?

Kamply builds the post or reel that answers it, on your brand's own tokens, with a brief first and a gate before anything is called done. Every ad on this wall was read into a competitor report; your reply to it is one brief away.

Download Kamply for Mac